Principal Financial Group’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$370K Sell
24,822
-1,442
-5% -$19.9K ﹤0.01% 2031
2026
Q2
$330K Buy
26,264
+7,587
+41% +$68.9K ﹤0.01% 2041
2026
Q1
$132K Buy
+18,677
New +$132K ﹤0.01% 2117

Other funds holding DRTS

Principal Financial Group's DRTS Position: Q3 2026 in Review

Principal Financial Group reduced its Alpha Tau Medical (DRTS) stake by 5.5% in Q3 2026, selling an estimated $19.9K and leaving 24,822 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

Principal Financial Group first reported a position in DRTS in Q1 2026 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold DRTS as of Q3 2026.

  • Principal Financial Group held 24,822 shares of Alpha Tau Medical worth $370K as of Q3 2026.
  • Principal Financial Group sold 1,442 Alpha Tau Medical shares in Q3 2026, an estimated $19.9K.
  • Alpha Tau Medical made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #2031 holding.
  • Principal Financial Group first reported a position in Alpha Tau Medical in Q1 2026 and has held it in 3 quarters since.
  • 27 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2026.

Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.